These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27006943)

  • 41. Proteinase-activated receptor-2 activation participates in allergic sensitization to house dust mite allergens in a murine model.
    Davidson CE; Asaduzzaman M; Arizmendi NG; Polley D; Wu Y; Gordon JR; Hollenberg MD; Cameron L; Vliagoftis H
    Clin Exp Allergy; 2013 Nov; 43(11):1274-85. PubMed ID: 24152160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2.
    McGuire JJ; Dai J; Andrade-Gordon P; Triggle CR; Hollenberg MD
    J Pharmacol Exp Ther; 2002 Dec; 303(3):985-92. PubMed ID: 12438518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of protease-activated receptor 2 is associated with blood pressure regulation and proteinuria reduction in metabolic syndrome.
    Maruyama-Fumoto K; McGuire JJ; Fairlie DP; Shinozuka K; Kagota S
    Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):211-220. PubMed ID: 33124085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate.
    Roviezzo F; De Angelis A; De Gruttola L; Bertolino A; Sullo N; Brancaleone V; Bucci M; De Palma R; Urbanek K; D'Agostino B; Ianaro A; Sorrentino R; Cirino G
    Clin Sci (Lond); 2014 Apr; 126(8):545-56. PubMed ID: 24131465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is the metabolic syndrome a real clinical entity and should it receive drug treatment?
    Darsow T; Kendall D; Maggs D
    Curr Diab Rep; 2006 Nov; 6(5):357-64. PubMed ID: 17076996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The induction of the collagen capsule synthesis by Trichinella spiralis is closely related to protease-activated receptor 2.
    Park MK; Cho MK; Kang SA; Kim BY; Yu HS
    Vet Parasitol; 2016 Oct; 230():56-61. PubMed ID: 27884442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist.
    Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN
    J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity associated disease risk: the role of inherent differences and location of adipose depots.
    Hill JH; Solt C; Foster MT
    Horm Mol Biol Clin Investig; 2018 Mar; 33(2):. PubMed ID: 29547393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time-Dependent Differences in the Influence of Perivascular Adipose Tissue on Vasomotor Functions in Metabolic Syndrome.
    Kagota S; Iwata S; Maruyama K; McGuire JJ; Shinozuka K
    Metab Syndr Relat Disord; 2017 Jun; 15(5):233-239. PubMed ID: 28358621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel agonists and antagonists for human protease activated receptor 2.
    Barry GD; Suen JY; Le GT; Cotterell A; Reid RC; Fairlie DP
    J Med Chem; 2010 Oct; 53(20):7428-40. PubMed ID: 20873792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway.
    Du C; Zhang T; Xiao X; Shi Y; Duan H; Ren Y
    Biochem J; 2017 Aug; 474(16):2733-2747. PubMed ID: 28694352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
    Schinzari F; Tesauro M; Cardillo C
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats.
    Holzhausen M; Spolidorio LC; Vergnolle N
    J Dent Res; 2005 Feb; 84(2):154-9. PubMed ID: 15668333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist Discovery.
    Perry SR; Xu W; Wirija A; Lim J; Yau MK; Stoermer MJ; Lucke AJ; Fairlie DP
    J Chem Inf Model; 2015 Jun; 55(6):1181-91. PubMed ID: 26000704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The development of proteinase-activated receptor-2 modulators and the challenges involved.
    McIntosh KA; Cunningham MR; Bushell T; Plevin R
    Biochem Soc Trans; 2020 Dec; 48(6):2525-2537. PubMed ID: 33242065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role/function of protease-activated receptor 2 on vascular endothelium in metabolic syndrome].
    Maruyama K; McGuire JJ; Shinozuka K; Kagota S
    Nihon Yakurigaku Zasshi; 2016 Mar; 147(3):135-8. PubMed ID: 26960771
    [No Abstract]   [Full Text] [Related]  

  • 58. Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy.
    Oe Y; Hayashi S; Fushima T; Sato E; Kisu K; Sato H; Ito S; Takahashi N
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1525-33. PubMed ID: 27283743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteinase-activated receptor-2 mediates arterial vasodilation in diabetes.
    Roviezzo F; Bucci M; Brancaleone V; Di Lorenzo A; Geppetti P; Farneti S; Parente L; Lungarella G; Fiorucci S; Cirino G
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2349-54. PubMed ID: 16141401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.